Enara Bio to Unveil First‑in‑Class DARKFOX‑Targeting Bispecific T Cell Engager ENA101 in Oral Presentation at AACR 2026, Showcasing Breakthrough Potential for Solid Tumor ...

March 17, 2026. Enara Bio, a pioneer in Dark Antigen® discovery and bispecific T cell engager innovation, today announced new data ...
Ghanaweb.com

GhIPSS, EDAPT sign new deal

Gabriel Ruhan, Chief Executive Officer (CEO) of EDAPT, has said UK-based Ghanaians can now receive remittances abroad directly on their e-Zwich cards following a deal between Unity Link and the Ghana ...
Yahoo Finance

Boehringer Ingelheim licenses multiple Dark Antigens® from Enara Bio to develop off-the-shelf immunotherapies for non-small cell lung cancer (NSCLC)

Licensed antigens are shared across major subsets of NSCLC and have confirmed presence on the surface of tumor cells, homogeneous expression within tumors, and strong immunogenicity Boehringer ...
inc42

Edapt - Company Profile & Overview

Founded in 2017, Edapt operates in Edtech offering technology education designed to empower students of all ages with essential skills for the Fourth Industrial ...